This week, following the Clarity Act’s failure, the CFTC filed its Regulation Crypto Asset Transactions and Regulation Crypto ...

The decision provides an important defense to claims that an AI tool violates the DMCA merely because it generates material ...

We are pleased to provide you with Gibson Dunn’s ESG Risk, Litigation, and Reporting update covering the following key ...

Partner Trey Cox discussed with Texas Lawyer why he is bullish on the use of artificial intelligence using proprietary ...

Gibson Dunn advised the Scaleup Europe Fund, managed by EQT, in connection with its lead investment in Tandem Health AB's ...

Gibson Dunn announced today that accomplished trial lawyers Kimberly Branscome, Yahonnes Cleary, and Jonathan Tam have joined ...

The SEC seeks to eliminate the Rule 14a-8 shareholder proposal framework, reform the voting framework applicable to ...

Partner Michael Bopp was quoted in Law360’s “Executive Privilege Questions Cloud Congressional Probe Prep,” which discusses how a U.S. Justice Department opinion on executive privilege could ...

Gibson Dunn is advising North Immunology, Inc. on its merger with Aethlon Medical, Inc., along with a concurrent private placement expected to fund the combined company's operations into the second ...

Gibson Dunn represented Amazon.com, Inc. (NASDAQ: AMZN) on its inaugural Sterling-denominated offering of £4.25 billion aggregate principal amount of notes, comprised of £1.25 billion of 5.200% notes ...

Partner Gregg Costa, a former federal trial and appellate judge, discussed his experiences with The AmLaw Litigation Daily.

Join Gibson Dunn lawyers for the first recorded session of a three-part series following a single life sciences collaboration ...